Matt Baird
Regional Vice President, Business Development, Claritev
There is a particular kind of stress that comes from driving at night on an unfamiliar road.
Your headlights only reach so far. Road signs appear late. You slow down, not because you lack skill, but because you lack visibility.
For years, that is what managing healthcare costs has felt like for employers and the brokers who advise them. Rising spend, constant plan adjustments, and limited insight into what care actually costs.
The Discount Era was a Low-Visibility Dashboard
In the absence of real price access, the industry learned to steer using proxies, especially network discounts off billed charges. Employers were told they were achieving strong savings. Brokers compared carriers based on reported discount percentages.
But discounts are not prices. They are percentages applied to a baseline that is often inflated and disconnected from actual reimbursement. Savings can appear significant without revealing true value.
Employers implemented wellness programs, adjusted plan designs, shifted to self-insurance, and added utilization controls, often without validating the unit economics driving the spend. It was a pricing problem managed without price visibility.
Now the Headlights are on
This moment is different.
The Transparency in Coverage rule requires carriers and self-funded plans to publish machine-readable files detailing negotiated in-network rates. The Consolidated Appropriations Act also prohibited contractual gag clauses that restricted access to cost data. For the first time, employers not only have public pricing visibility, they have legal protection to access and use cost information tied to their plans.
This is a structural shift.
Commercial healthcare claims exceed one trillion dollars annually. Prices for the same procedure can vary by 40 to 50 percent within a single metro area. Employers routinely pay 175 to 300 percent of Medicare rates for identical hospital services depending on geography and network. When variation at that scale becomes visible, the implications are financially significant.
The challenge now is not obtaining transparency. The challenge is using it effectively.
Why Transparency Still Feels Difficult
Anyone who has attempted to review a machine-readable file understands the complexity. The files are enormous. Formats vary. Data can be incomplete. Without context raw data can be misinterpreted, and that can lead to confusing billing structures, site of care differences, or case mix variation for meaningful price discrepancies.
That complexity leads some to dismiss transparency as impractical.
That reaction misses the point.
When we are on the road, we do not abandon GPS because it occasionally misroutes. We use it because it is far better than driving without it. The same principle applies here. Imperfect data, applied intelligently, is superior to navigating in the dark.
Transparency is not the solution by itself. It is the foundation.
From Visibility to Usable Insight
The next era of healthcare cost management will not be defined by who has access to data. Access is now public. It will be defined by who can convert raw visibility into objective, comparable, and actionable insight.
Objective transparency changes the conversation in three ways.
First, it replaces proxies with facts. Instead of discussing discounts, the conversation becomes about actual unit prices and how they compare across carriers and facilities.
Second, it enables earlier decisions. When high-cost services and pricing outliers are visible, brokers and employers can act before renewal pressure limits flexibility.
Third, it strengthens negotiation leverage. Carrier discussions shift from percentage narratives to price comparisons grounded in evidence.
Leading brokers are already using transparency data to evaluate utilization patterns, benchmark provider reimbursement, assess network competitiveness, and refine population-level strategy. Those who operationalize these capabilities will differentiate themselves quickly.
Transparency is Still Uneven
Progress has not been uniform across healthcare.
Medical reimbursement data is publicly accessible. Pharmacy economics remain structurally opaque. Manufacturer rebates, spread pricing, and vertically integrated pharmacy models obscure the true net cost of drugs, particularly in specialty categories that represent a growing share of employer spend.
Until pharmacy pricing becomes more transparent, the visibility available on the medical side becomes even more important. It is where actionable clarity already exists and where strategic improvements can be made today.
What Comes Next
If transparency functions as headlights, benchmarking and normalization act as lane markers.
To translate complexity into decisions:
- Focus first on high-cost, high-volume services where variation drives meaningful impact.
- Normalize rates against consistent reference points such as Medicare percentages to enable valid comparisons.
- Segment data by geography and site of care to identify localized inefficiencies.
- Use pricing evidence to strengthen renewal strategy, plan design discussions, and stop-loss negotiations.
- Translate analytics into clear explanations that decision-makers can understand and act on.
Clarity in Action
Data visibility alone does not create value. Transparency only works when it becomes usable.
The road ahead remains complex. Healthcare pricing is fragmented and incentives continue to evolve. But we are no longer driving in the dark.
The next era will not be defined by who has data. It will be defined by who can turn that data into disciplined strategy, measurable advantage, and clearer decisions.
For brokers and employers ready to lead, that opportunity is already here.
Ready to get started?
Download our latest white paper featuring a proven framework for brokers and employers to take control of healthcare costs.